About 300 people will have the vaccine over the coming weeks, as part of a trial led by Prof Robin Shattock and his colleagues, at Imperial College London, AzVision.az reports citing BBC News.
Tests in animals suggest the vaccine is safe and triggers an effective immune response.
Experts at Oxford University have already started human trials.
The trials are among many across the world - there are around 120 vaccine programmes under way.
After this first phase, another trial is being planned for October, involving 6,000 people.
The Imperial team hopes the vaccine could be distributed in the UK and overseas from early 2021.